aTYR PHARMA INC - ATYR

Sector: Healthcare · Industry: Biological Products, (No Diagnostic Substances)
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q4 2025 · Q3 2025
Value (USD)
Total reported value ($000)
$56.53M
QoQ value delta ($000)
-$2.135M (-3.64%)
Implied price effect (QoQ)
+23.99%
Shares
Total shares
55,909,674
QoQ shares delta
-16,033,454 (-22.29%)
Total shares held by funds (by quarter)

Market chart (ATYR)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q4 2025)

Top 25 only Full list
Early Q1 2026 data: only 13 institutional holders reported so far. More will appear as funds file with the SEC.
Manager Value ($000) Shares % of 13F
Rosalind Advisors, Inc. 13,601 1,039,080 4.78%
FMR LLC 11,510 14,697,995 0.0%
FEDERATED HERMES, INC. 8,230 10,509,678 0.01%
BlackRock, Inc. 5,129 6,549,699 0.0%
VANGUARD GROUP INC 3,885 4,961,871 0.0%
GSA CAPITAL PARTNERS LLP 2,060 2,630,638 0.18%
GEODE CAPITAL MANAGEMENT, LLC 1,788 2,283,717 0.0%
STATE STREET CORP 1,350 1,724,843 0.0%
UBS Group AG 1,272 1,625,297 0.0%
MORGAN STANLEY 1,098 1,403,009 0.0%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 852 1,089,343 0.0%
TWO SIGMA ADVISERS, LP 658 841,350 0.0%
AQR CAPITAL MANAGEMENT LLC 602 769,820 0.0%
NORTHERN TRUST CORP 549 702,186 0.0%
JANE STREET GROUP, LLC 409 523,349 0.0%
Tikvah Management LLC 360 460,833 0.1%
TWO SIGMA INVESTMENTS, LP 355 454,443 0.0%
CITADEL ADVISORS LLC 298 381,000 0.0%
GOLDMAN SACHS GROUP INC 270 345,587 0.0%
Nuveen, LLC 178 227,941 0.0%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 173 221,767 0.0%
Bank of New York Mellon Corp 151 193,532 0.0%
GROUP ONE TRADING LLC 149 191,048 0.0%
VICTORY CAPITAL MANAGEMENT INC 142 181,966 0.0%
BARCLAYS PLC 136 174,182 0.0%